Table 5.

Comparison of SUV between data at 12 months after last dose and baseline

Patient no.	Basal ganglia		Central region		Cerebellum		Cingulate and paracingulate gyri		Frontal lobe		Mesial temporal lobe		Occipital lobe		Parietal lobe		Temporal lobe
	L	R	L	R	L	R	L	R	L	R	L	R	L	R	L	R	L	R
Control group (n = 8)
1	1.12	1.56	1.03	1.16	0.90	0.82	1.11	1.25	1.17	1.08	1.00	0.67	1.00	0.99	1.12	1.16	1.24	1.03
2	1.20	1.03	0.85	0.79	0.69	0.75	0.98	0.94	1.08	1.03	0.76	0.70	0.97	0.98	0.98	0.96	0.99	0.90
3	1.15	1.14	1.23	1.12	1.16	1.11	1.04	1.06	1.06	1.08	1.13	1.08	1.09	1.02	1.16	1.05	1.10	1.05
4	0.98	0.99	0.99	0.99	0.96	0.95	1.04	1.00	1.01	0.99	0.97	0.97	1.07	1.07	1.03	1.00	1.01	0.99
5	0.86	0.95	1.09	1.13	1.26	1.25	1.15	1.17	1.20	1.24	1.10	1.11	1.14	1.17	1.23	1.18	0.99	1.06
6	1.08	1.09	1.08	1.13	1.12	1.11	1.05	1.09	1.04	1.07	1.14	1.15	1.14	1.12	1.12	1.09	1.12	1.15
7	0.95	0.97	0.97	0.98	1.09	1.11	1.06	1.04	1.01	0.98	0.97	0.93	0.93	1.01	0.98	1.05	1.06	1.06
8	0.93	0.97	1.02	1.05	1.05	1.08	1.10	1.08	1.10	1.12	0.93	1.00	1.21	1.29	1.14	1.09	1.07	1.14
hUC-MSC group (n = 5)
9	1.25	1.14	1.69	1.62	1.03	0.96	1.45	1.36	1.40	1.24	1.08	1.04	1.88	1.75	2.04	1.78	1.34	1.23
10	1.12	0.89	0.94	0.96	1.11	1.14	0.90	0.85	1.14	1.06	0.81	0.84	1.02	1.01	1.10	1.11	1.10	0.87
11	2.97	3.66	3.35	2.94	3.27	3.08	2.78	2.60	3.68	3.94	1.71	3.07	4.83	5.62	2.81	4.19	3.75	4.25
12	1.59	1.70	1.73	1.77	1.72	1.65	1.73	1.68	1.73	1.76	1.73	1.75	1.89	1.83	1.81	1.73	1.83	1.79
13	6.91	6.44	6.72	7.71	4.88	5.21	6.45	6.72	6.99	7.24	4.38	3.05	7.62	7.58	7.87	6.77	8.98	8.36

Data was calculated with SUV2 divided by SUV1. SUV1 referred to mean SUV at baseline. SUV2 referred to mean SUV at 12 months after last dose

Abbreviations: hUC-MSC human umbilical cord-derived mesenchymal stem cell